Computer Aided Diagnosis (CADx) for Colorectal Polyps Resect-and-Discard Strategy
Launched by CHINESE UNIVERSITY OF HONG KONG · Sep 28, 2023
Trial Information
Current as of July 22, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new approach to identifying colorectal polyps during colonoscopy using artificial intelligence (AI). The goal is to see if a computer-aided diagnosis (CADx) system can accurately help doctors determine whether polyps are non-cancerous or require further treatment. Currently, when polyps are found, they are usually removed and sent for testing to confirm their nature, which can be costly and time-consuming. This trial aims to compare the effectiveness of the AI system in real-time against the traditional method of diagnosis during colonoscopy.
To participate in this trial, you need to be undergoing a colonoscopy for reasons like screening or monitoring and have at least one polyp detected. However, if you have a personal history of colorectal cancer, inflammatory bowel disease, or have had previous colorectal surgery, you won't be eligible. Participants can expect to have their polyps assessed using this new AI technology during the procedure, which could potentially simplify the process and reduce the need for extensive testing afterward. This trial is currently recruiting and is open to individuals of all ages.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • undergoing elective colonoscopy with any indication (screening, surveillance or diagnostic) and complete colonoscopy (caecal intubation) with at least one colorectal polyp detected will be recruited
- Exclusion Criteria:
- • personal history of CRC or inflammatory bowel disease, prior colorectal surgery, receiving anticoagulant therapy
- • lack of informed consent
About Chinese University Of Hong Kong
The Chinese University of Hong Kong (CUHK) is a prestigious research institution renowned for its commitment to advancing medical science and improving healthcare outcomes. As a clinical trial sponsor, CUHK leverages its extensive academic resources and interdisciplinary expertise to conduct innovative research that addresses critical health challenges. The university fosters collaboration among leading researchers, healthcare professionals, and industry partners, ensuring rigorous study design and implementation. CUHK is dedicated to upholding the highest ethical standards in clinical research, with a focus on translating findings into tangible benefits for patients and the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Hong Kong, , Hong Kong
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported